Uterotonic Plants and their Bioactive Constituents
Open Access
- 15 September 2010
- journal article
- review article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 77 (03) , 207-220
Abstract
Abnormalities in the process of uterine muscle contractility during pregnancy and birth can have major clinical implications, including preterm labour, which is the single largest cause of maternal and prenatal mortality in the Western world and a major contributor to childhood developmental problems. In contrast, induction of labour may be necessary in certain conditions. Currently used interventional therapies to suppress (tocolytic agents) or to induce (uterotonic agents) uterine contractions lack potency and/or selectivity and can have harmful side effects for mother and baby. Nature's diversity has always been, and still is, one of the biggest resources of therapeutic lead compounds. Many natural products exhibit biological activity against unrelated targets, thus providing researchers with starting points for drug development. In this review we will provide an overview of uterine muscle physiology, describe currently available biological screening procedures for testing of uterotonic plant compounds and will summarise traditionally-used uterotonic plants, their active components and their mechanisms, primarily focusing on uterotonic active circular plant peptides called cyclotides. Finally we will comment on the discovery of novel cyclotide-producing plant species and the possibility for the development of novel plant-derived uterotonic and tocolytic drugs.Keywords
This publication has 172 references indexed in Scilit:
- Mechanisms of labour—biochemical aspectsBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- Papaya (Carica papaya) consumption is unsafe in pregnancy: fact or fable? Scientific evaluation of a common belief in some parts of Asia using a rat modelBritish Journal of Nutrition, 2002
- Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cellsExperimental Physiology, 2000
- Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motifJournal of Molecular Biology, 1999
- The Prostaglandin E2and F2αReceptor Genes Are Expressed in Human Myometrium and Are Down-regulated during PregnancyBiochemical and Biophysical Research Communications, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Fetal and Maternal Oxytocin in Human ParturitionAmerican Journal of Perinatology, 1989
- Local stimulation of prostagiandin production by corttcotropin-releasing hormone in human fetal membranes and placentaBiochemical and Biophysical Research Communications, 1989
- Plants used for reproductive health in Oaxaca, MexicoEconomic Botany, 1985
- Effect of cervical application of prostaglandin (PG) E2 on plasma 13,14‐dihydro‐15‐keto‐PGF2α and oxytocin in pregnant women at termBJOG: An International Journal of Obstetrics & Gynaecology, 1983